Global genomic diagnostics company Veracyte, Inc. recently announced new appointments to key leadership positions within the company.
To strengthen the company's leadership and advance its global expansion agenda, Veracyte appointed Rob Brainin to the positions of executive VP and chief business officer and Bill Zondler to the positions of senior VP and chief information officer, the company said in a release.
Marc Stapley, Veracyte’s CEO, welcomed the two leaders to the company.
"I’m delighted that Rob and Bill will join Veracyte’s leadership team," Stapley said. "Both executives are seasoned life sciences leaders with proven track records for building successful organizations in complex and dynamic environments."
Brainin joins the leadership team after more than 20 years of executive experience in health care and life sciences. His most recent position was as CEO of Genuity Science.
"Rob will lead our biopharmaceutical partnerships, including leveraging opportunities from our recent and in-process acquisitions, as well as our strategic planning and business development," Stapley said.
Zondler brings more than 25 years of experience in information technology and will play a key role in the company's global expansion, the company said. He previously served as chief information officer at Biotheranostics, Inc.
"Bill will build out our global IT infrastructure, ensuring our ability to serve clinical customers and patients across our broad products and geographies," Stapley said. "Ultimately, these leaders will help Veracyte execute on our powerful vision of improving outcomes for patients all over the world at every step of their journey.”
Headquartered in San Francisco, Veracyte specializes in genomic tests for cancer of the lungs, prostate, breast, thyroid and bladder as well as idiopathic pulmonary fibrosis.